These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16481886)

  • 1. Targeting reactive oxygen species in hypertension.
    Cifuentes ME; Pagano PJ
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):179-86. PubMed ID: 16481886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
    Paravicini TM; Touyz RM
    Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
    Montezano AC; Touyz RM
    Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH oxidase inhibitors: new antihypertensive agents?
    Williams HC; Griendling KK
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):9-16. PubMed ID: 17666910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is mycophenolate more than just an immunosuppressant?--An overview.
    Iyer A; Brown L
    Indian J Biochem Biophys; 2009 Feb; 46(1):25-30. PubMed ID: 19374250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD(P)H oxidase and endothelial dysfunction.
    Muller G; Morawietz H
    Horm Metab Res; 2009 Feb; 41(2):152-8. PubMed ID: 18816427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
    Matsubara M; Akizuki O; Ikeda J; Saeki K; Yao K; Sasaki K
    Eur J Pharmacol; 2008 Feb; 580(1-2):201-13. PubMed ID: 18048030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons: role of neuronal NADPH oxidase.
    Park KW; Jin BK
    J Neurosci Res; 2008 Apr; 86(5):1053-63. PubMed ID: 18183616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II and oxidative stress.
    Hitomi H; Kiyomoto H; Nishiyama A
    Curr Opin Cardiol; 2007 Jul; 22(4):311-5. PubMed ID: 17556883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of oxidative stress in the endothelium and vascular wall.
    Jiang F; Drummond GR; Dusting GJ
    Endothelium; 2004; 11(2):79-88. PubMed ID: 15370067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin-triggered lipoxin A4 blocks reactive oxygen species generation in endothelial cells: a novel antioxidative mechanism.
    Nascimento-Silva V; Arruda MA; Barja-Fidalgo C; Fierro IM
    Thromb Haemost; 2007 Jan; 97(1):88-98. PubMed ID: 17200775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases.
    Cai H; Griendling KK; Harrison DG
    Trends Pharmacol Sci; 2003 Sep; 24(9):471-8. PubMed ID: 12967772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.
    Gao L; Mann GE
    Cardiovasc Res; 2009 Apr; 82(1):9-20. PubMed ID: 19179352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide adenine dinucleotide phosphate oxidase and diabetes: vascular implications.
    Maier KG
    Vasc Endovascular Surg; 2008; 42(4):305-13. PubMed ID: 18621880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of reactive oxygen species in brainstem in neural mechanisms of hypertension.
    Hirooka Y
    Auton Neurosci; 2008 Nov; 142(1-2):20-4. PubMed ID: 18650132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular NADPH oxidases as drug targets for novel antioxidant strategies.
    Guzik TJ; Harrison DG
    Drug Discov Today; 2006 Jun; 11(11-12):524-33. PubMed ID: 16713904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases.
    San José G; Fortuño A; Beloqui O; Díez J; Zalba G
    Clin Sci (Lond); 2008 Feb; 114(3):173-82. PubMed ID: 18184111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelins and NADPH oxidases in the cardiovascular system.
    Dammanahalli KJ; Sun Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):2-6. PubMed ID: 18047620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.